Allena Pharmaceuticals Inc. (ALNA) Stock Price

4.285 ▲ +0.065 (+1.54%)
Open: 4.27 Vol: 42.83K Day's range: 4.27 - 4.285 Sep 17, 13:12 EDT
IEX Real-Time Price
Free Stock Screener
Loading chart ...
ALNA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY NEUTRAL
  5 mins 30 mins Hourly Daily Weekly
MA5 4.28▲ 4.28▲ 4.27▲ 4.24▲ 4.16▲
MA10 4.28▲ 4.26▲ 4.27▲ 4.20▲ 4.13▲
MA20 4.28▲ 4.28▲ 4.26▲ 4.21▲ 4.40▼
MA50 4.26▲ 4.25▲ 4.20▲ 4.27▲ 6.32▼
MA100 4.17▲ 4.12▲ 4.13▲ 4.64▼ N/A    
MA200 4.19▲ 4.40▼ 4.43▼ 5.94▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.001▼ -0.003▼ -0.003▼ 0.018▲ N/A    
RSI 51.468▲ 51.931▲ 52.202▲ 53.259▲ N/A    
STOCH 73.469     78.111     65.290     46.095     26.536    
WILL %R -16.327▲ -33.871     -33.871     -44.471     -71.465    
CCI 43.698     13.719     23.168     114.163▲ -25.356    
Latest Filters Detected On ALNA
CDL $ALNA Doji Candlestick Pattern Detected Set Alert
CDL $ALNA Harami Candlestick Pattern Detected Set Alert
MA $ALNA Price Crossed Above MA(50) Set Alert
Allena Pharmaceuticals Inc. News
Allena Pharmaceuticals Completes Enrollment in Pivotal Phase 3 URIROX-1 Trial Evaluating Reloxaliase in Patients with Enteric Hyperoxaluria
Monday, September 16, 2019 05:03 AM
September 16, 2019 08:00 ET | Source: Allena Pharmaceuticals, Inc. NEWTON, Mass., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical ...
Allena Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Enteric Hyperoxaluria and Potential for Reloxaliase
Wednesday, September 11, 2019 05:04 AM
September 11, 2019 08:00 ET | Source: Allena Pharmaceuticals, Inc. NEWTON, Mass., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical ...
Allena Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Enteric Hyperoxaluria and Potential for Reloxaliase
Wednesday, September 11, 2019 05:03 AM
NEWTON, Mass., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral ...
ALNA historical stock data
date open high low close volume
17/09/19 4.27 4.285 4.27 4.285 42,830
16/09/19 4.35 4.35 4.115 4.22 22,300
13/09/19 4.07 4.29 4.07 4.23 10,300
12/09/19 4.24 4.28 4.10 4.24 33,800
11/09/19 4.28 4.32 4.06 4.23 22,200
10/09/19 4.21 4.422 4.21 4.27 34,900
09/09/19 4.06 4.34 4.06 4.22 53,600
06/09/19 4.06 4.37 4.06 4.08 37,800
05/09/19 4.09 4.4732 4.09 4.17 32,607
04/09/19 4.35 4.35 4.05 4.10 50,000
Quote Details
52wk Low:3.72
52wk High:11.82
Vol:42.83K
Avg Vol(3m):1.2M
1Y Chng:-59.42%
1M Chng:+6.86%
Add to Watch List
More Information
Index NASDAQ Composite
Market Cap. 98.32M